Dual intracellular targeting by ruxolitinib and Mcl-1 inhibitor S63845 in IL-6 dependent myeloma cells blocks in vivo tumor growth.

Please login or register to bookmark this article
Bookmark this %label%

Not available.

View the full article @ Haematologica
Get PDF with LibKey

Authors: Renate Burger, Anna Otte, Jan Brdon, Matthias Peipp, Martin Gramatzki